Company news

Alpha Tau Medical Ltd news in 2025

Alpha Tau Medical Ltd's news releases, calls and decks from 2025, newest first.

View company

Alpha Tau to Present at the J.P. Morgan 2026 Healthcare Conference

December 18, 2025

Alpha Tau Successfully Treats First Patient in its U.S. Trial for Patients with Recurrent Glioblastoma at the James Cancer Hospital at The Ohio State University

December 9, 2025

Alpha Tau Announces Presentation of Two Alpha DaRT Pancreatic Cancer Abstracts at Upcoming 2026 ASCO GI Symposium

December 4, 2025

Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Locally Recurrent Prostate Cancer

December 2, 2025

Alpha Tau to Participate in December Investor Conferences

December 1, 2025

Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update

November 20, 2025

Alpha Tau to Participate at Jefferies Global Healthcare Conference in London

November 11, 2025

Alpha Tau Announces Receipt of Radioactive Material License for its New Hampshire Manufacturing Facility, Advancing Towards Commercial Readiness

October 21, 2025

Alpha Tau Successfully Treats First Patient in its U.S. Multi-Center Pancreatic Cancer Clinical Trial

September 2, 2025

Alpha Tau to Participate in Five September Investor Conferences

August 27, 2025

Alpha Tau Announces Second Quarter 2025 Financial Results and Provides Corporate Update

August 11, 2025

Alpha Tau to Present at Jefferies Global Healthcare Conference

May 28, 2025

Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update

May 19, 2025

Alpha Tau Announces Appointment of Nadav Kidron to its Board of Directors

May 12, 2025

Alpha Tau to Participate in May Investor Conferences

May 6, 2025

Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals

April 28, 2025

Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma

April 2, 2025

Alpha Tau Announces Full Year 2024 Financial Results and Provides Corporate Update

March 12, 2025

Alpha Tau to Participate in March Investor Conferences

February 27, 2025

Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification

February 24, 2025

Decks in 2025